Psyllid ID: psy11331


Local Sequence Feature Prediction

Prediction and (Method)Result
Residue Number Marker
Protein Sequence ?
Secondary Structure (PSIPRED) ?
Secondary Structure Prediction (SSPRO) ?
Coil and Loop (DISEMBL) ?
Flexible Loop (DISEMBL) ?
Low Complexity Region (SEG) ?
Disordered region (IsUnstruct) ?
Disordered Region (DISOPRED) ?
Disordered Region (DISEMBL) ?
Disordered Region (DISPRO) ?
Transmembrane Helix (TMHMM) ?
Transmembrane Helix (HMMTOP) ?
Transmembrane Helix (MEMSAT) ?
TM Helix, Signal Peptide (Phobius) ?
Signal Peptide (SignalP HMM Mode) ?
Signal Peptide (SignalP NN Mode) ?
Coiled Coils (COILS) ?
Positional Conservation ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780
MTNLFTLLLLGVFSAEGFNGHFKVIEVLIVDARTTIHKYNKELYSGPKLRPGQGPSLYNSKNDRVLTENLLREVVDKMGRDLADAYFDLPDLDSTNQNGRATDVDKDFDAVNPQTGFDYPESNNSPGHSPSLRDQEYLQQSSLWGHQFVQDLKEGTVTVKVQAIPLASGIRSIYSRAVSGDISSYKEMTNLFTLLLLGVFSAEGFNGHFKNDRVLTENLLREVVDKMGRDLADAYFDLPDLDSTNQNGRATDVDKDFDAVNPQTGFDYPESNNSPGHSPSLRDQEYLQQSSLWGHQFVQGGAGEGKQLLKPEGSIKNQNQVKTDATLPAYCNPPNPCPVGYTAEDGCLEDFENSAEYSRVYQAAQECMCDAEHMFASVPIPYLLKMELKLGLLLLLCLHTALPFGFDDIETIFDITEKTVSTLSKAPEIAELVNHANKDSEIKLPFSKTRRQLIPMFKKFAEVTRIVKKIDRDLIASNMQTISQLQKDLPIAFRFELKLDAIEDTITLIELYYQNFLSYTDQAQEHYKESNQIDSNTQTSTSQPAPNIKFDKYTLENFATSLTSHVPTSVRGLMERINEMIVPSSRDTVRIFMREGIFQTVVKTFNVYLTIKCREILVSFQYQVGSVGHGLGGLQYAGKVASVFTWFWFLMEPSGGAGEGKQLLKPEGSIKNQNQVKTDATLPAYCNPPNPCPVGYTAEDGCLEDFENSAEYSRVYQAAQECMCDAEHMFACPQEPPQHNPNEIEYSPFLNPDKNPYLQGDMLPIAAKKGNNVPKIMALE
ccHHHHHHHHHHHHccccccccEEEEEEEEccHHHHHHHHHHHHccccccccccccccccccccHHHHHHHHHHHHHHcccHHHHccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHcccccHHHccccccccEEcccccEEcccHHHHHHccccccccHHHHHHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccHHHHcccccccccEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccHHHHHHHHHHHcccccccHHHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
cccHHHHHHHHHHHHHHHccccEEEEEEEEccHHHHHHHHHHHHccccccccccccHHccccccHHHHHHHHHHHHHHcHHHHHHccccccccccccccccccccccccccccccccHHHHccccccccccHcHHHHHHHcccHHHHHHHccccccEEEEEEEEEHHHHHHHHHHHccccccccHHHHHHHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHHHHHcccHHcHcccccccccccccccccHHHHHHHcHHHHcccccccHccccccccccccHHHHccccccccEEEccccccccccccccccccccEEEEcccccccccccccccccccccccccccccccHHHHHHHHHHHcccccccccccccccccccHHHHHHHHHHHcccHEEccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccHHHHHHHHcHHHHHHHHHHEEEEccccccccHHHHHHHHHccccccccccccccccccccccHcHHHHHHHHHHccccccHHHHHHHHHEEEEEcccccEEEEccHHHHHHHHHcHHHHHHHHHHHHHHHHHHHHHHcccccccccEHHHHHHHHHHcccccEEccccccccccccccccccccHHcccccccccccccccccccccccccccccccccHHHHHHHHHHHcccccccccccccccccccccccHHEEccccccccccccccccccEEEcccccccHEEEcc
MTNLFTLLLLGVfsaegfngHFKVIEVLIVDARTTIHKYNkelysgpklrpgqgpslynskndrvLTENLLREVVDKMGRDLADayfdlpdldstnqngratdvdkdfdavnpqtgfdypesnnspghspslrdqeyLQQSSLWGHQFVQDLKEGTVTVKVQAIPLASGIRSIYsravsgdissyKEMTNLFTLLLLGVfsaegfnghfkndrVLTENLLREVVDKMGRDLADayfdlpdldstnqngratdvdkdfdavnpqtgfdypesnnspghspslrdqeYLQQsslwghqfvqggagegkqllkpegsiknqnqvktdatlpaycnppnpcpvgytaedgcledfenSAEYSRVYQAAQECMCdaehmfasvpipYLLKMELKLGLLLLLCLHtalpfgfddiETIFDITEKTVSTLSKAPEIAELVNhankdseiklpfsktrRQLIPMFKKFAEVTRIVKKIDRDLIASNMQTISQLQKDLPIAFRFELKLDAIEDTITLIELYYQNFLSYTDQAQEHykesnqidsntqtstsqpapnikfdkytlenfatsltshvptsVRGLMERINemivpssrdTVRIFMREGIFQTVVKTFNVYLTIKCREILVSFQYQvgsvghglgglQYAGKVASVFTWFWFlmepsggagegkqllkpegsiknqnqvktdatlpaycnppnpcpvgytaedgcledfenSAEYSRVYQAAQECMcdaehmfacpqeppqhnpneieyspflnpdknpylqgdmlpiaakkgnnvpkimale
MTNLFTLLLLGVFSAEGFNGHFKVIEVLIVDARTTIHKYNKelysgpklrpgqgpslynskndrvlTENLLREVVDKMGRDLADAYFDLPDLDSTNQNGRATDVDKDFDAVNPQTGFDYPESNNSPGHSPSLRDQEYLQQSSLWGHQFVQDLKEGTVTVKVQaiplasgirsiysRAVSGDISSYKEMTNLFTLLLLGVFSAEGFNGHFKNDRVLTENLLREVVDKMGRDLADAYFDLPDLDSTNQNGRATDVDKDFDAVNPQTGFDYPESNNSPGHSPSLRDQEYLQQSSLWGHQFVQGGAGEGKQLLKPEGSIKNQNQVKTDATLPAYCNPPNPCPVGYTAEDGCLEDFENSAEYSRVYQAAQECMCDAEHMFASVPIPYLLKMELKLGLLLLLCLHTALPFGFDDIETIFDITEKTVSTLSKAPEIAElvnhankdseiklpfsktrrqlIPMFKKFAEVTRIVKKIDRDLIASNMQTISQLQKDLPIAFRFELKLDAIEDTITLIELYYQNFLSYTDQAQEHYKESNQidsntqtstsqpapNIKFDKYTLENFAtsltshvptsvRGLMERINEmivpssrdTVRIFMREGIFQTVVKTFNVYLTIKCREILVSFQYQVGSVGHGLGGLQYAGKVASVFTWFWFLMEPSGGAGEGKQLLKPEGSIKNQNQVKTDATLPAYCNPPNPCPVGYTAEDGCLEDFENSAEYSRVYQAAQECMCDAEHMFACPQEPPQHNPNEIEYSPFLNPDKNPYLQGDMlpiaakkgnnvpkimale
MTNLFTLLLLGVFSAEGFNGHFKVIEVLIVDARTTIHKYNKELYSGPKLRPGQGPSLYNSKNDRVLTENLLREVVDKMGRDLADAYFDLPDLDSTNQNGRATDVDKDFDAVNPQTGFDYPESNNSPGHSPSLRDQEYLQQSSLWGHQFVQDLKEGTVTVKVQAIPLASGIRSIYSRAVSGDISSYKEMTNLFTLLLLGVFSAEGFNGHFKNDRVLTENLLREVVDKMGRDLADAYFDLPDLDSTNQNGRATDVDKDFDAVNPQTGFDYPESNNSPGHSPSLRDQEYLQQSSLWGHQFVQGGAGEGKQLLKPEGSIKNQNQVKTDATLPAYCNPPNPCPVGYTAEDGCLEDFENSAEYSRVYQAAQECMCDAEHMFASVPIPYllkmelklglllllclhtalPFGFDDIETIFDITEKTVSTLSKAPEIAELVNHANKDSEIKLPFSKTRRQLIPMFKKFAEVTRIVKKIDRDLIASNMQTISQLQKDLPIAFRFELKLDAIEDTITLIELYYQNFLSYTDQAQEHYKESNQIDSNTQTSTSQPAPNIKFDKYTLENFATSLTSHVPTSVRGLMERINEMIVPSSRDTVRIFMREGIFQTVVKTFNVYLTIKCREILVSFQYQVGSVGHGLGGLQYAGKVASVFTWFWFLMEPSGGAGEGKQLLKPEGSIKNQNQVKTDATLPAYCNPPNPCPVGYTAEDGCLEDFENSAEYSRVYQAAQECMCDAEHMFACPQEPPQHNPNEIEYSPFLNPDKNPYLQGDMLPIAAKKGNNVPKIMALE
***LFTLLLLGVFSAEGFNGHFKVIEVLIVDARTTIHKYNKELYS******************RVLTENLLREVVDKMGRDLADAYFDL***************************************************SSLWGHQFVQDLKEGTVTVKVQAIPLASGIRSIYSRAVSGDISSYKEMTNLFTLLLLGVFSAEGFNGHFKNDRVLTENLLREVVDKMGRDLADAYFDLP****************************************************LWGHQFV***************************TLPAYCNPPNPCPVGYTAEDGCLEDFENSAEYSRVYQAAQECMCDAEHMFASVPIPYLLKMELKLGLLLLLCLHTALPFGFDDIETIFDITEKTVSTLSKAPEIAELVNHA****EIKLPFSKTRRQLIPMFKKFAEVTRIVKKIDRDLIASNMQTISQLQKDLPIAFRFELKLDAIEDTITLIELYYQNFLSYTD***************************KFDKYTLENFATSLTSHVPTSVRGLMERINEMIVPSSRDTVRIFMREGIFQTVVKTFNVYLTIKCREILVSFQYQVGSVGHGLGGLQYAGKVASVFTWFWFLME****************************TLPAYCNPPNPCPVGYTAEDGCLEDFENSAEYSRVYQAAQECMCDAEHMFAC************************************************
**NLFTLLLLGVFSAEGFNGHFKVIEVLIVDARTTIHKYNKELYSGPKLRPGQG******KNDRVLTENLLREVVDKMGRDLADAYFDLPDL***************************************LRDQEYLQQSSLWGHQF*************QAIPLASGIRSIYSRAVSGDISSYKEMTNLFTLLLLGVFSAEGFNGHFKNDRVLTENLLREVVDKMGRDLADAYFDLP*************************GFDYPESNNSPG*SPSLRDQEYLQQSSLW******************************DATLPAYCNPPNPCPVGYTAEDGCLEDFENSAEYSRVYQAAQECMCDAEHMFASVPIPYLLKMELKLGLLLLLCLHTALPFGFDDIETIFDITEKTVSTLSKAPEIAELVNHANKDSEIKLPFSKTRRQLIP*FK***E***I*KKIDRDLIASNMQTISQLQKDLPIAFRFELKLDAIEDTITLIELYYQNFLSYTDQAQ*******QIDSNTQTSTSQPAPNIKFDKYTLENFATSLTSHVPTSVRGLMERINEMIVPSSRDTVRIFMREGIFQTVVKTFN***********VSFQYQVGSVGHGLGGLQYAGKVASVFTWFWFLMEP***************************TLPAYCNPPNPCPVGYTAEDGCLEDFENSAEYSRVYQAAQECMCDAEHMFAC****************************DMLPIAAKKGNNVP*I****
MTNLFTLLLLGVFSAEGFNGHFKVIEVLIVDARTTIHKYNKELYSGPKLRPGQGPSLYNSKNDRVLTENLLREVVDKMGRDLADAYFDLPDLDSTNQNGRATDVDKDFDAVNPQTGFDYPE***********RDQEYLQQSSLWGHQFVQDLKEGTVTVKVQAIPLASGIRSIYSRAVSGDISSYKEMTNLFTLLLLGVFSAEGFNGHFKNDRVLTENLLREVVDKMGRDLADAYFDLPDLDSTNQNGRATDVDKDFDAVNPQTGFDYPE***********RDQEYLQQSSLWGHQFVQGGAGEGKQLLKPEGSIKNQNQVKTDATLPAYCNPPNPCPVGYTAEDGCLEDFENSAEYSRVYQAAQECMCDAEHMFASVPIPYLLKMELKLGLLLLLCLHTALPFGFDDIETIFDITEKTVSTLSKAPEIAELVNHANKDSEIKLPFSKTRRQLIPMFKKFAEVTRIVKKIDRDLIASNMQTISQLQKDLPIAFRFELKLDAIEDTITLIELYYQNFLSYTDQAQEHY****************PAPNIKFDKYTLENFATSLTSHVPTSVRGLMERINEMIVPSSRDTVRIFMREGIFQTVVKTFNVYLTIKCREILVSFQYQVGSVGHGLGGLQYAGKVASVFTWFWFLMEPSGGAGEGKQLLKPEGSIKNQNQVKTDATLPAYCNPPNPCPVGYTAEDGCLEDFENSAEYSRVYQAAQECMCDAEHMFACPQEPPQHNPNEIEYSPFLNPDKNPYLQGDMLPIAAKKGNNVPKIMALE
*TNLFTLLLLGVFSAEGFNGHFKVIEVLIVDARTTIHKYNKELYSGPKLRPGQGPSLYNSKNDRVLTENLLREVVDKMGRDLADAYFDLPDLDS*NQNGRATDVDKDFDAVNPQTGFDYPESNNSPGHSPSLRDQEYLQQSSLWGHQFVQDLKEGTVTVKVQAIPLASGIRSIYSRAVSGDISSYKEMTNLFTLLLLGVFSAEGFNGHFKNDRVLTENLLREVVDKMGRDLADAYFDLPDLDSTNQNGRATDVDKDFDAVNPQTGFDYPESNNSPGHSPSLRDQEYLQQSSLWGHQFVQGGAGEGKQLLKPEGSIKNQNQVKTDATLPAYCNPPNPCPVGYTAEDGCLEDFENSAEYSRVYQAAQECMCDAEHMFASVPIPYLLKMELKLGLLLLLCLHTALPFGFDDIETIFDITEKTVSTLSKAPEIAELVNHANKDSEIKLPFSKTRRQLIPMFKKFAEVTRIVKKIDRDLIASNMQTISQLQKDLPIAFRFELKLDAIEDTITLIELYYQNFLSYTDQAQEHYKESN**********SQPAPNIKFDKYTLENFATSLTSHVPTSVRGLMERINEMIVPSSRDTVRIFMREGIFQTVVKTFNVYLTIKCREILVSFQYQVGSVGHGLGGLQYAGKVASVFTWFWFLMEPSGGAGEGKQLLKPEGSIKNQNQVKTDATLPAYCNPPNPCPVGYTAEDGCLEDFENSAEYSRVYQAAQECMCDAEHMFACPQEPPQHNPNEIEYSPFLNPDKNPYLQGDMLPIAAKKGNNVPKIMALE
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
SSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MTNLFTLLLLGVFSAEGFNGHFKVIEVLIVDARTTIHKYNKELYSGPKLRPGQGPSLYNSKNDRVLTENLLREVVDKMGRDLADAYFDLPDLDSTNQNGRATDVDKDFDAVNPQTGFDYPESNNSPGHSPSLRDQEYLQQSSLWGHQFVQDLKEGTVTVKVQAIPLASGIRSIYSRAVSGDISSYKEMTNLFTLLLLGVFSAEGFNGHFKNDRVLTENLLREVVDKMGRDLADAYFDLPDLDSTNQNGRATDVDKDFDAVNPQTGFDYPESNNSPGHSPSLRDQEYLQQSSLWGHQFVQGGAGEGKQLLKPEGSIKNQNQVKTDATLPAYCNPPNPCPVGYTAEDGCLEDFENSAEYSRVYQAAQECMCDAEHMFASVPIPYLLKMELKLGLLLLLCLHTALPFGFDDIETIFDITEKTVSTLSKAPEIAELVNHANKDSEIKLPFSKTRRQLIPMFKKFAEVTRIVKKIDRDLIASNMQTISQLQKDLPIAFRFELKLDAIEDTITLIELYYQNFLSYTDQAQEHYKESNQIDSNTQTSTSQPAPNIKFDKYTLENFATSLTSHVPTSVRGLMERINEMIVPSSRDTVRIFMREGIFQTVVKTFNVYLTIKCREILVSFQYQVGSVGHGLGGLQYAGKVASVFTWFWFLMEPSGGAGEGKQLLKPEGSIKNQNQVKTDATLPAYCNPPNPCPVGYTAEDGCLEDFENSAEYSRVYQAAQECMCDAEHMFACPQEPPQHNPNEIEYSPFLNPDKNPYLQGDMLPIAAKKGNNVPKIMALE
no confident homologs detected

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST ?

ID ?Alignment graph ?Length ? Definition ? RBH(Q2H) ? RBH(H2Q) ? Q cover ? H cover ? Identity ? E-value ?
Query780 2.2.26 [Sep-21-2011]
P05408212 Neuroendocrine protein 7B yes N/A 0.115 0.424 0.428 8e-12
P12961212 Neuroendocrine protein 7B yes N/A 0.148 0.547 0.362 1e-11
P27682210 Neuroendocrine protein 7B yes N/A 0.148 0.552 0.362 2e-11
P18844161 Neuroendocrine protein 7B N/A N/A 0.114 0.552 0.438 9e-11
A5A6J6211 Neuroendocrine protein 7B yes N/A 0.114 0.421 0.418 6e-10
P01165207 Neuroendocrine protein 7B yes N/A 0.147 0.555 0.355 1e-09
>sp|P05408|7B2_HUMAN Neuroendocrine protein 7B2 OS=Homo sapiens GN=SCG5 PE=1 SV=2 Back     alignment and function desciption
 Score = 73.2 bits (178), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 42/98 (42%), Positives = 57/98 (58%), Gaps = 8/98 (8%)

Query: 288 QQSSLWGHQFVQGGAGEGKQLLKPEGSIKNQNQVKTDATLP-------AYCNPPNPCPVG 340
           Q  +L G Q ++GGA EG Q L P G+I N     T   +P        Y +PPNPCPVG
Sbjct: 64  QAMNLVGPQSIEGGAHEGLQHLGPFGNIPNIVAELTGDNIPKDFSEDQGYPDPPNPCPVG 123

Query: 341 YTAEDGCLEDFENSAEYSRVYQAAQECMCDAEHMFASV 378
            TA+DGCLE+  ++AE+SR +Q  Q  + D EH +  +
Sbjct: 124 KTADDGCLENTPDTAEFSREFQLHQH-LFDPEHDYPGL 160




Acts as a molecular chaperone for PCSK2/PC2, preventing its premature activation in the regulated secretory pathway. Binds to inactive PCSK2 in the endoplasmic reticulum and facilitates its transport from there to later compartments of the secretory pathway where it is proteolytically matured and activated. Also required for cleavage of PCSK2 but does not appear to be involved in its folding. Plays a role in regulating pituitary hormone secretion. The C-terminal peptide inhibits PCSK2 in vitro.
Homo sapiens (taxid: 9606)
>sp|P12961|7B2_MOUSE Neuroendocrine protein 7B2 OS=Mus musculus GN=Scg5 PE=1 SV=1 Back     alignment and function description
>sp|P27682|7B2_RAT Neuroendocrine protein 7B2 OS=Rattus norvegicus GN=Scg5 PE=1 SV=1 Back     alignment and function description
>sp|P18844|7B2_XENLA Neuroendocrine protein 7B2 (Fragment) OS=Xenopus laevis GN=sgne1 PE=1 SV=1 Back     alignment and function description
>sp|A5A6J6|7B2_PANTR Neuroendocrine protein 7B2 OS=Pan troglodytes GN=SCG5 PE=2 SV=1 Back     alignment and function description
>sp|P01165|7B2_PIG Neuroendocrine protein 7B2 OS=Sus scrofa GN=SCG5 PE=1 SV=2 Back     alignment and function description

Close Homologs in the Non-Redundant Database Detected by BLAST ?

GI ?Alignment Graph ?Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query780
242025271260 conserved hypothetical protein [Pediculu 0.207 0.623 0.613 1e-52
270006284300 hypothetical protein TcasGA2_TC008457 [T 0.229 0.596 0.5 7e-43
91081787256 PREDICTED: similar to neuroendocrine pro 0.203 0.621 0.539 1e-42
312377495 1362 hypothetical protein AND_11183 [Anophele 0.197 0.113 0.550 4e-42
118789379248 AGAP008082-PA [Anopheles gambiae str. PE 0.197 0.620 0.550 5e-41
211908636309 neuroendocrine protein 7B2 precursor [De 0.124 0.313 0.793 1e-40
170031583247 neuroendocrine protein 7b2 [Culex quinqu 0.225 0.712 0.494 2e-40
357616774238 neuroendocrine protein 7b2 [Danaus plexi 0.225 0.739 0.479 3e-40
328699675252 PREDICTED: neuroendocrine protein 7B2-li 0.211 0.654 0.462 6e-40
157126249245 neuroendocrine protein 7b2 [Aedes aegypt 0.192 0.612 0.532 8e-39
>gi|242025271|ref|XP_002433049.1| conserved hypothetical protein [Pediculus humanus corporis] gi|212518565|gb|EEB20311.1| conserved hypothetical protein [Pediculus humanus corporis] Back     alignment and taxonomy information
 Score =  214 bits (546), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 103/168 (61%), Positives = 128/168 (76%), Gaps = 6/168 (3%)

Query: 212 DRVLTENLLREVVDKMGRDLA---DAYFDLPDLDSTNQNGRATD-VDKDFDAVNPQTGFD 267
           +  LT+ L R+VVD+MG+DLA   D+Y D+PD +    NG  ++ V KD +        D
Sbjct: 25  EHFLTDLLFRDVVDRMGKDLAEAADSYLDMPDNERLQTNGFLSNRVIKDLENEETSDPID 84

Query: 268 YPESNNSPGHSPSLRDQEYLQQSSLWGHQFVQGGAGEGKQLLKPEGSIKNQNQVKTDATL 327
           Y   +N+P  +PSLRD+EYLQ SSLWGHQFV GGAGEGKQ LKP+GS++NQ QVKTD TL
Sbjct: 85  YDRLSNNP--NPSLRDREYLQHSSLWGHQFVAGGAGEGKQRLKPDGSVQNQQQVKTDETL 142

Query: 328 PAYCNPPNPCPVGYTAEDGCLEDFENSAEYSRVYQAAQECMCDAEHMF 375
           PAYCNPPNPCP+GYT EDGCLE+FEN+A +SR YQ +Q+CMCD+EHMF
Sbjct: 143 PAYCNPPNPCPIGYTGEDGCLEEFENTAAFSRDYQTSQDCMCDSEHMF 190




Source: Pediculus humanus corporis

Species: Pediculus humanus

Genus: Pediculus

Family: Pediculidae

Order: Phthiraptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|270006284|gb|EFA02732.1| hypothetical protein TcasGA2_TC008457 [Tribolium castaneum] Back     alignment and taxonomy information
>gi|91081787|ref|XP_973692.1| PREDICTED: similar to neuroendocrine protein 7b2 [Tribolium castaneum] Back     alignment and taxonomy information
>gi|312377495|gb|EFR24311.1| hypothetical protein AND_11183 [Anopheles darlingi] Back     alignment and taxonomy information
>gi|118789379|ref|XP_317375.3| AGAP008082-PA [Anopheles gambiae str. PEST] gi|116123190|gb|EAA12615.3| AGAP008082-PA [Anopheles gambiae str. PEST] Back     alignment and taxonomy information
>gi|211908636|gb|ACJ12615.1| neuroendocrine protein 7B2 precursor [Dermacentor variabilis] Back     alignment and taxonomy information
>gi|170031583|ref|XP_001843664.1| neuroendocrine protein 7b2 [Culex quinquefasciatus] gi|167870492|gb|EDS33875.1| neuroendocrine protein 7b2 [Culex quinquefasciatus] Back     alignment and taxonomy information
>gi|357616774|gb|EHJ70395.1| neuroendocrine protein 7b2 [Danaus plexippus] Back     alignment and taxonomy information
>gi|328699675|ref|XP_003241011.1| PREDICTED: neuroendocrine protein 7B2-like isoform 2 [Acyrthosiphon pisum] gi|328699677|ref|XP_001944445.2| PREDICTED: neuroendocrine protein 7B2-like isoform 1 [Acyrthosiphon pisum] gi|328699679|ref|XP_003241012.1| PREDICTED: neuroendocrine protein 7B2-like isoform 3 [Acyrthosiphon pisum] gi|328699681|ref|XP_003241013.1| PREDICTED: neuroendocrine protein 7B2-like isoform 4 [Acyrthosiphon pisum] Back     alignment and taxonomy information
>gi|157126249|ref|XP_001654557.1| neuroendocrine protein 7b2 [Aedes aegypti] gi|108882529|gb|EAT46754.1| AAEL002055-PA [Aedes aegypti] Back     alignment and taxonomy information

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST ?

ID ? Alignment graph ? Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query780
FB|FBgn0041707276 7B2 "7B2" [Drosophila melanoga 0.226 0.641 0.385 8.7e-35
WB|WBGene00011392211 sbt-1 [Caenorhabditis elegans 0.120 0.445 0.595 9.6e-29
UNIPROTKB|Q9XTY3211 sbt-1 "Protein SBT-1" [Caenorh 0.120 0.445 0.595 9.6e-29
UNIPROTKB|F1NCP2209 SCG5 "Uncharacterized protein" 0.111 0.416 0.431 1.2e-12
UNIPROTKB|P05408212 SCG5 "Neuroendocrine protein 7 0.108 0.400 0.451 1.6e-12
UNIPROTKB|C9JNY7194 SCG5 "N-terminal peptide" [Hom 0.108 0.438 0.451 1.6e-12
UNIPROTKB|H7C4X7216 SCG5 "N-terminal peptide" [Hom 0.108 0.393 0.451 1.6e-12
UNIPROTKB|P18844161 sgne1 "Neuroendocrine protein 0.110 0.534 0.452 2.6e-12
MGI|MGI:98289212 Scg5 "secretogranin V" [Mus mu 0.108 0.400 0.440 3.3e-12
RGD|3669210 Scg5 "secretogranin V (7B2 pro 0.108 0.404 0.440 3.3e-12
FB|FBgn0041707 7B2 "7B2" [Drosophila melanogaster (taxid:7227)] Back     alignment and assigned GO terms
 Score = 330 (121.2 bits), Expect = 8.7e-35, Sum P(2) = 8.7e-35
 Identities = 74/192 (38%), Positives = 109/192 (56%)

Query:   191 LFTLLLLGVFSAEGFNGH-FKNDRVLTENLLREVVDKMGRDLADAYFDLPDLDSTNQNGR 249
             ++ ++ + V +  G+    +    +L + L+ +++++M +D+   Y+D+ +  +      
Sbjct:    13 VYMMVAMLVVALSGYQVQSYSAKDILADVLMTDLLNRMDKDMQVGYYDVGNEAAAGSKDN 72

Query:   250 ATDVDKDFDAVNPQTGFD-YPESNNSPGHS--PSLRDQEYLQQSSLWGHQFVQGGAGEGK 306
                V +   A     G D   +S ++ G +  PSLRD E+LQ SSLWGHQF+ GG GEG 
Sbjct:    73 VDLVSRSEYARLCDGGSDCILQSGSASGAASHPSLRDDEFLQHSSLWGHQFISGGMGEG- 131

Query:   307 QLLKPEGSIKNQNQVKTDATLPAYCNPPNPCPVGYTAED---GCLEDFENSAEYSRVYQA 363
                 P    +    VK DA LPAYCNPPNPCP GY  E     C+ DFEN+A +SR +QA
Sbjct:   132 ----PN---RYPTIVKNDAGLPAYCNPPNPCPEGYDMETQGGSCIVDFENTAIFSREFQA 184

Query:   364 AQECMCDAEHMF 375
             AQ+C CD EHMF
Sbjct:   185 AQDCTCDNEHMF 196


GO:0016486 "peptide hormone processing" evidence=ISS
GO:0045862 "positive regulation of proteolysis" evidence=IDA
GO:0010952 "positive regulation of peptidase activity" evidence=IDA
GO:0016504 "peptidase activator activity" evidence=IDA
GO:0007218 "neuropeptide signaling pathway" evidence=IEA
GO:0030141 "secretory granule" evidence=IEA
WB|WBGene00011392 sbt-1 [Caenorhabditis elegans (taxid:6239)] Back     alignment and assigned GO terms
UNIPROTKB|Q9XTY3 sbt-1 "Protein SBT-1" [Caenorhabditis elegans (taxid:6239)] Back     alignment and assigned GO terms
UNIPROTKB|F1NCP2 SCG5 "Uncharacterized protein" [Gallus gallus (taxid:9031)] Back     alignment and assigned GO terms
UNIPROTKB|P05408 SCG5 "Neuroendocrine protein 7B2" [Homo sapiens (taxid:9606)] Back     alignment and assigned GO terms
UNIPROTKB|C9JNY7 SCG5 "N-terminal peptide" [Homo sapiens (taxid:9606)] Back     alignment and assigned GO terms
UNIPROTKB|H7C4X7 SCG5 "N-terminal peptide" [Homo sapiens (taxid:9606)] Back     alignment and assigned GO terms
UNIPROTKB|P18844 sgne1 "Neuroendocrine protein 7B2" [Xenopus laevis (taxid:8355)] Back     alignment and assigned GO terms
MGI|MGI:98289 Scg5 "secretogranin V" [Mus musculus (taxid:10090)] Back     alignment and assigned GO terms
RGD|3669 Scg5 "secretogranin V (7B2 protein)" [Rattus norvegicus (taxid:10116)] Back     alignment and assigned GO terms

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries ?

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by EFICAz Software ?

No EC number assignment, probably not an enzyme!


Prediction of Functionally Associated Proteins


Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query780
pfam05281210 pfam05281, Secretogranin_V, Neuroendocrine protein 8e-53
pfam05281210 pfam05281, Secretogranin_V, Neuroendocrine protein 6e-50
pfam05281210 pfam05281, Secretogranin_V, Neuroendocrine protein 0.002
>gnl|CDD|218535 pfam05281, Secretogranin_V, Neuroendocrine protein 7B2 precursor (Secretogranin V) Back     alignment and domain information
 Score =  182 bits (462), Expect = 8e-53
 Identities = 68/126 (53%), Positives = 81/126 (64%), Gaps = 7/126 (5%)

Query: 257 FDAVNPQTGFDYPESNNSPGHS-------PSLRDQEYLQQSSLWGHQFVQGGAGEGKQLL 309
            D  +P+T     E++              + RD EYL  S+L G Q + GGAGEG Q L
Sbjct: 18  DDDYSPRTPDLVSEADIQRLLHGVMEQLGIARRDVEYLAHSALVGPQSISGGAGEGLQHL 77

Query: 310 KPEGSIKNQNQVKTDATLPAYCNPPNPCPVGYTAEDGCLEDFENSAEYSRVYQAAQECMC 369
            P G+I N   VKTD  LPAYCNPPNPCPVG TA+DGCLE+FEN+AE+SR YQA Q+C C
Sbjct: 78  GPYGNIPNIVAVKTDDNLPAYCNPPNPCPVGKTADDGCLENFENTAEFSREYQAHQDCFC 137

Query: 370 DAEHMF 375
           D EHMF
Sbjct: 138 DPEHMF 143


The neuroendocrine protein 7B2 has a critical role in the proteolytic conversion and activation of proPC2, the enzyme responsible for the proteolytic conversion of many peptide hormone precursors. The 7B2 protein acts as an intracellular binding protein for proPC2, facilitates its maturation, and is required for its enzymatic activity. Processing of many important peptide precursors does not occur in 7B2 nulls. 7B2 null mice exhibit a unique form of Cushing's disease with many atypical symptoms, such as hypoglycemia. Length = 210

>gnl|CDD|218535 pfam05281, Secretogranin_V, Neuroendocrine protein 7B2 precursor (Secretogranin V) Back     alignment and domain information
>gnl|CDD|218535 pfam05281, Secretogranin_V, Neuroendocrine protein 7B2 precursor (Secretogranin V) Back     alignment and domain information

Conserved Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query 780
PF05281208 Secretogranin_V: Neuroendocrine protein 7B2 precur 100.0
PF05281208 Secretogranin_V: Neuroendocrine protein 7B2 precur 100.0
KOG4187|consensus228 100.0
KOG4187|consensus228 100.0
>PF05281 Secretogranin_V: Neuroendocrine protein 7B2 precursor (Secretogranin V); InterPro: IPR007945 Mature peptide hormones and neuropeptides are typically synthesised from much larger precursors and require several post-translational processing steps--including proteolytic cleavage--for the formation of the bioactive species Back     alignment and domain information
Probab=100.00  E-value=2.6e-64  Score=486.91  Aligned_cols=158  Identities=56%  Similarity=0.969  Sum_probs=142.4

Q ss_pred             HHHHHHHhhccccc---ccccCCCCCccccCCCcccccccccccCCCCCCCCCCCCCCCCCCCCcccccccccCCCccce
Q psy11331        220 LREVVDKMGRDLAD---AYFDLPDLDSTNQNGRATDVDKDFDAVNPQTGFDYPESNNSPGHSPSLRDQEYLQQSSLWGHQ  296 (780)
Q Consensus       220 LrelvnrMgkDl~d---~YlD~~~~dr~~~~~s~a~v~kdl~~v~eql~~dy~rl~~~~Np~PSlRDqEylqHSsLwGhQ  296 (780)
                      ++|||+||++||+.   +|+.     ++.+.+|+.++.++++++++             +++||+||+|||+|++|||||
T Consensus         1 ~~~l~~~m~~~l~~a~~~~~~-----~~~D~~s~~~~~~~~~~~~e-------------~~~~s~Rd~E~l~hssLwG~q   62 (208)
T PF05281_consen    1 MTELLNRMGNDLAAAADSYLP-----RNVDRVSESEYARLLDGVME-------------NPGPSLRDQEYLQHSSLWGHQ   62 (208)
T ss_pred             ChHHHHHHHhhhhhhhhhcCc-----cccchhhhHHHHHhhccccc-------------cCCCCccccccccccccCCce
Confidence            58999999999988   4444     56777888888999988775             689999999999999999999


Q ss_pred             eecCCCCCCCcccCCCCCCCccccccCCCCCCCCCCCCCCCCCCccCCCCcccCccchHHhhHHHHhcccCCCCcccccc
Q psy11331        297 FVQGGAGEGKQLLKPEGSIKNQNQVKTDATLPAYCNPPNPCPVGYTAEDGCLEDFENSAEYSRVYQAAQECMCDAEHMFA  376 (780)
Q Consensus       297 ~IsGGAGEG~Q~L~P~G~i~N~~~vKTD~~LPAYCnPPNPCPvGYTaeDgCledFENTAeFSReyQa~QdCmCDtEHMF~  376 (780)
                      ||+||||||.|+|+|+|+|+|+++||||++||||||||||||+|||++|||+++|||||+|||+||++||||||+||||+
T Consensus        63 ~isGGagEG~q~L~~~~~i~n~~~~ktd~~lPaYCnPPNPCPvGyt~~dgCle~fEnTAeFSReyQa~QdC~CD~EHMf~  142 (208)
T PF05281_consen   63 YISGGAGEGPQHLGPEGNIPNIKIVKTDNNLPAYCNPPNPCPVGYTAEDGCLENFENTAEFSREYQAAQDCMCDTEHMFD  142 (208)
T ss_pred             eeeCCCCccchhcCccCCcCcccccccccCCCCCCCCCCCCCCCcccccCcccCCccHHHhhHHHHhcCccCCCcccccC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCcchHH--HhhhHHHHHHH
Q psy11331        377 SVPIPYLLK--MELKLGLLLLL  396 (780)
Q Consensus       377 C~P~~s~~~--~~~~l~~~~~~  396 (780)
                      | |......  ++..|+.+|..
T Consensus       143 C-~~~~~~d~~~~~~l~~~~~~  163 (208)
T PF05281_consen  143 C-PSQENSDSGNNSSLEKFMHE  163 (208)
T ss_pred             C-ccccccchhhhhHHHHHhhh
Confidence            9 7544422  67777776544



The subtilisin-related proteolytic enzymes that accomplish neuroendocrine-specific cleavages are known as prohormone convertases 1 and 2 (PC1 and PC2), which belong to MEROPS peptidase family S8B. The cell biology of these proteases within the regulated secretory pathway of neuroendocrine cells is complex, and they are themselves initially synthesised as inactive precursor molecules. ProPC1 propeptide cleavage occurs rapidly in the endoplasmic reticulum, yet its major site of action on prohormones takes place later in the secretory pathway. PC1 undergoes an interesting carboxyl terminal processing event whose function appears to be to activate the enzyme. ProPC2, on the other hand, exhibits comparatively long initial folding times and exits the endoplasmic reticulum without propeptide cleavage, in association with the neuroendocrine-specific protein 7B2. Once the proPC2/7B2 complex arrives at the trans-Golgi network, 7B2 is internally cleaved into two domains, the 21kDa fragment and a carboxy-terminal 31 residue peptide. PC2 propeptide removal occurs in the maturing secretory granule, most likely through autocatalysis, and 7B2 association does not appear to be directly required for this cleavage event. However, if proPC2 has not encountered 7B2 intracellularly, it cannot generate a catalytically active mature species. The molecular mechanism behind the intriguing intracellular association of 7B2 and proPC2 is still unknown, but may involve conformational rearrangement or stabilisation of a proPC2 conformer mediated by a 36-residue internal segment of 21kDa 7B2. This family represents, 7B2 (secretogranin V), which is the molecular escort protein for PC2. 7B2 is a bifunctional protein with an N-terminal activation domain and a C-terminal inhibitory domain (MEROPS inhibitor family I21, clan I-) separated by a furin cleavage site []. Although 7B2 represents a potent inhibitor of PC2, there is an absolute requirement of 7B2 for the activation of PC2, which is synthesised as a zymogen. Both the full length, 27 kDa, and the C-terminal peptide (CT domain) derived from intramolecular cleavage of 7B2 are potent inhibitors of PC2. Studies have shown that the active peptide in the CT domain to be LLRVHK, active in the nanomolar range not only against PC2 but also PC1 [, ]. Knock-out studies have shown that the PC2 nulls are not phenotypically equivalent to the 7B2 nulls, which suggests that 7B2 may have other activities in addition to being the activator of PC2 []. 7B2 exhibits both structural and functional homology to proSAAS (IPR010832 from INTERPRO), which is the PC1 binding protein. The CT domain of proSAAS contains the same inhibitor hexapeptide as 7B2, consequently both 7B2 and proSAAS are two members of a homologous family of prohormone convertase inhibitor proteins. ; GO: 0007218 neuropeptide signaling pathway, 0030141 stored secretory granule

>PF05281 Secretogranin_V: Neuroendocrine protein 7B2 precursor (Secretogranin V); InterPro: IPR007945 Mature peptide hormones and neuropeptides are typically synthesised from much larger precursors and require several post-translational processing steps--including proteolytic cleavage--for the formation of the bioactive species Back     alignment and domain information
>KOG4187|consensus Back     alignment and domain information
>KOG4187|consensus Back     alignment and domain information

Homologous Structure Templates

Structure Templates Detected by BLAST ?

No homologous structure with e-value below 0.005

Structure Templates Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query780
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 5e-12
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 5e-06
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
 Score = 68.7 bits (167), Expect = 5e-12
 Identities = 88/644 (13%), Positives = 198/644 (30%), Gaps = 173/644 (26%)

Query: 148 FVQDLKEGTVTVKVQAIPLASGIRSIYSRAVSGDISSYKEMTNLF-TLLLLGVFSAEGFN 206
           FV +          + +      +SI S+     I        +  TL L     ++   
Sbjct: 29  FVDNFD-------CKDVQ--DMPKSILSKEEIDHI--IMSKDAVSGTLRLFWTLLSKQ-- 75

Query: 207 GHFKNDRVLTENLLREVVDKMGRD----LADAYFDLPDLDSTNQNGRATDVDKDFDAVNP 262
                     E ++++ V+++ R     L           S          D+ ++    
Sbjct: 76  ----------EEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQV 125

Query: 263 QTGFDYPESNNSPGHSPSLRDQEYLQ-QSSLWGHQ-----FVQGGAGEGKQLLKPEGSIK 316
              F       +  +    R Q YL+ + +L   +      + G  G GK  +       
Sbjct: 126 ---F-------AKYNVS--RLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVA------ 167

Query: 317 NQNQVKTDATLPAYCNPPNP---CPVG-YTAEDGCLEDFENSAEYSRVYQAAQECMCDAE 372
               V     +   C          +    + +  LE  +       +YQ        ++
Sbjct: 168 --LDVCLSYKV--QCKMDFKIFWLNLKNCNSPETVLEMLQK-----LLYQIDPNWTSRSD 218

Query: 373 HMFASVPIP----------YLLKMELKLGLLLLLCLHTALPFGFDDI---ETI--FDITE 417
           H  +++ +            L     +  LL+L            ++   +    F+++ 
Sbjct: 219 HS-SNIKLRIHSIQAELRRLLKSKPYENCLLVL-----------LNVQNAKAWNAFNLSC 266

Query: 418 KTVSTLSKAPEIAELVNHANKDSEIKLPFSK---TRRQLIPMFKKFAEVT-----RIVKK 469
           K + T ++  ++ + ++ A   + I L       T  ++  +  K+ +       R V  
Sbjct: 267 KILLT-TRFKQVTDFLS-AATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLT 324

Query: 470 IDRDLIASNMQTISQLQKDLPIAFRFE-LKLDAIEDTITLIELYYQNFLSYTDQAQEHYK 528
            +   ++     I++  +D      ++  K    +   T+IE    N L   +  ++ + 
Sbjct: 325 TNPRRLS----IIAESIRDGLA--TWDNWKHVNCDKLTTIIESSL-NVLEPAEY-RKMFD 376

Query: 529 ------ESNQIDSNT-----QTSTSQPAPNI--KFDKYTLENFATSLTSHVPTSVRGLME 575
                  S  I +                 +  K  KY+L      +      S   +  
Sbjct: 377 RLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSL------VEKQPKESTISIPS 430

Query: 576 RINEMIVPSSRDTVRIFMREGIFQTVVKTFNVYLTIKCREILV------SFQYQVGSVGH 629
              E+ V    +         + +++V  +N+  T    +++        + +    +GH
Sbjct: 431 IYLELKVKLENEYA-------LHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSH----IGH 479

Query: 630 GLGGLQYAGKVA---SVFTWFWFLMEPSGGAGEGKQLLKPEGSIKNQNQVKTD--ATLPA 684
            L  +++  ++     VF  F FL        E K  ++ + +  N +    +    L  
Sbjct: 480 HLKNIEHPERMTLFRMVFLDFRFL--------EQK--IRHDSTAWNASGSILNTLQQLKF 529

Query: 685 YCN--PPNPCPVGYTAEDGCLEDF-----EN--SAEYSRVYQAA 719
           Y      N  P  Y      + DF     EN   ++Y+ + + A
Sbjct: 530 YKPYICDN-DPK-YERLVNAILDFLPKIEENLICSKYTDLLRIA 571


>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure

Structure Templates Detected by HHsearch ?

No hit with probability above 80.00


Homologous Structure Domains

Structure Domains Detected by RPS-BLAST ?

No hit with e-value below 0.005

Homologous Domains Detected by HHsearch ?

No hit with probability above 80.00